Erratum: Correlation of clinical and immunological data in a metastatic melanoma patient with heterogeneous tumor responses to ipilimumab therapy

Ítems similars

• Correlation of clinical and immunological data in a metastatic melanoma patient with heterogeneous tumor responses to ipilimumab therapy
  per: Yuan, Jianda, et al.
  Publicat: (2010)
• Integrated NY-ESO-1 antibody and CD8(+) T-cell responses correlate with clinical benefit in advanced melanoma patients treated with ipilimumab
  per: Yuan, Jianda, et al.
  Publicat: (2011)
• CTLA-4 blockade enhances polyfunctional NY-ESO-1 specific T cell responses in metastatic melanoma patients with clinical benefit
  per: Yuan, Jianda, et al.
  Publicat: (2008)
• Immunological Insights from Patients Undergoing Surgery on Ipilimumab for Metastatic Melanoma
  per: Gyorki, David E., et al.
  Publicat: (2013)
• Enhancement of tumor-reactive cytotoxic CD4(+) T cell responses after ipilimumab treatment in four advanced melanoma patients
  per: Kitano, Shigehisa, et al.
  Publicat: (2013)